MCM
NVAX icon

McKinley Capital Management’s Novavax NVAX Stock Holding History

McKinley Capital Management’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-49,048
Closed -$7.13M – 562
2016
Q2 		$7.13M Buy
49,048
+24,466
+100% +$2.8M 0.35% 97
2016
Q1 		$2.54M Sell
24,582
-19
-0.1% -$2.04K 0.12% 161
2015
Q4 		$4.13M Buy
24,601
+17
+0.1% +$2.62K 0.19% 137
2015
Q3 		$3.48M Sell
24,584
-17,377
-41% -$3.9M 0.17% 145
2015
Q2 		$9.35M Sell
41,961
-71
-0.2% -$12.5K 0.4% 68
2015
Q1 		$6.95M Sell
42,032
-7,850
-16% -$1.27M 0.28% 102
2014
Q4 		$5.92M Sell
49,882
-303
-0.6% -$31.7K 0.24% 117
2014
Q3 		$4.18M Sell
50,185
-8
-0% -$723 0.18% 132
2014
Q2 		$4.64M Buy
50,193
+27,206
+118% +$2.39M 0.19% 128
2014
Q1 		$2.08M Sell
22,987
-32
-0.1% -$3.58K 0.09% 176
2013
Q4 		$2.36M Sell
23,019
-10,004
-30% -$707K 0.09% 177
2013
Q3 		$2.08M Buy
33,023
+39
+0.1% +$2.2K 0.09% 177
2013
Q2 		$1.35M Buy
+32,984
New +$1.43M 0.07% 182

Other funds holding NVAX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

McKinley Capital Management's NVAX Position: Q3 2016 in Review

McKinley Capital Management sold out of Novavax (NVAX) in Q3 2016, closing a stake of 49,048 shares — an estimated $7.13M sold.

McKinley Capital Management first reported a position in NVAX in Q2 2013 and held it in 13 quarters. The position peaked at $9.35M in Q2 2015. 165 funds tracked by Wall St. Rank hold NVAX as of Q3 2016.

  • McKinley Capital Management reported no remaining Novavax position as of Q3 2016 after selling out during the quarter.
  • McKinley Capital Management sold 49,048 Novavax shares in Q3 2016, an estimated $7.13M.
  • McKinley Capital Management first reported a position in Novavax in Q2 2013 and held it in 13 quarters.
  • McKinley Capital Management's Novavax position peaked at $9.35M in Q2 2015.
  • 165 funds tracked by Wall St. Rank held Novavax as of Q3 2016.

Based on McKinley Capital Management's 13F filing for Q3 2016, filed 14 Nov 2016.